Cytek Biosciences, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 44.1M | 62.1M | 52.3M | 45.6M | 41.5M | 57.5M | 51.5M | 46.6M |
| Cost of Goods Sold | 22.9M | 29.3M | 24.7M | 21.7M | 21.3M | 23.8M | 22.5M | 21.2M |
| Gross Profit | 21.3M | 32.9M | 27.6M | 23.9M | 20.2M | 33.7M | 29.0M | 25.4M |
| R&D Expenses | 9.6M | 9.0M | 9.0M | 8.8M | 9.7M | 9.7M | 9.9M | 10.0M |
| Operating Expenses | 39.7M | 38.5M | 36.7M | 34.5M | 35.1M | 30.7M | 33.3M | 34.0M |
| Operating Income | -18.5M | -5.6M | -9.2M | -10.6M | -15.0M | 3.0M | -4.2M | -8.5M |
| Other Income / Gains | 1.1M | 1.6M | 1.4M | 3.8M | 3.7M | 7.3M | 4.4M | 1.3M |
| Net Income | -18.9M | -44.1M | -5.5M | -5.6M | -11.4M | 9.6M | 941K | -10.4M |
| EPS (Diluted) | -0.15 | -0.34 | -0.043 | -0.044 | -0.09 | 0.074 | 0.007 | -0.079 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.482 | 0.529 | 0.527 | 0.523 | 0.486 | 0.585 | 0.563 | 0.546 |
| General And Administrative Expenses | 18.5M | 16.4M | 16.1M | 13.5M | 12.9M | 9.1M | 10.9M | 11.7M |
| Selling And Marketing Expenses | 11.6M | 13.1M | 11.7M | 12.1M | 12.5M | 11.9M | 12.4M | 12.3M |
| Selling General And Administrative Expenses | 30.1M | 29.5M | 27.8M | 25.7M | 25.4M | 20.9M | 23.4M | 24.0M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 62.6M | 67.7M | 61.5M | 56.2M | 56.4M | 54.5M | 55.7M | 55.1M |
| Interest Income | 787K | 580K | 573K | 555K | 508K | 6.2M | 1.4M | 1.4M |
| Interest Expense | 262K | 725K | 494K | 414K | 291K | 0 | 119K | 134K |
| Depreciation And Amortization | 2.8M | 3.0M | 3.1M | 3.0M | 2.9M | 2.7M | 2.8M | 2.5M |
| Ebitda | -15.7M | -263K | -4.2M | -3.4M | -8.1M | -2.5M | 3.1M | -4.6M |
| Ebitdaratio | -0.355 | -0.004 | -0.081 | -0.074 | -0.195 | -0.043 | 0.06 | -0.098 |
| Operating Income Ratio | -0.418 | -0.09 | -0.176 | -0.233 | -0.361 | 0.052 | -0.082 | -0.183 |
| Income Before Tax | -17.4M | -4.0M | -7.8M | -6.8M | -11.3M | 10.3M | 157K | -7.2M |
| Income Before Tax Ratio | -0.394 | -0.065 | -0.149 | -0.149 | -0.272 | 0.18 | 0.003 | -0.154 |
| Income Tax Expense | 1.5M | 40.0M | -2.3M | -1.2M | 136K | 680K | -784K | 3.2M |
| Net Income Ratio | -0.427 | -0.709 | -0.105 | -0.122 | -0.275 | 0.168 | 0.018 | -0.224 |
| Epsdiluted | -0.15 | -0.34 | -0.043 | -0.044 | -0.09 | 0.073 | 0.007 | -0.079 |
| Weighted Average Shs Out | 128.7M | 128.2M | 127.5M | 126.9M | 128.3M | 129.2M | 131.0M | 131.4M |
| Weighted Average Shs Out Dil | 128.7M | 128.2M | 127.5M | 126.9M | 128.3M | 129.2M | 132.8M | 131.4M |